Global Excellence in Experimental Pharmacology and Drug Discovery 2022: North America

5,669
Total downloads
38k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 28 Feb 2024

Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes

Ninoschka C. D’Souza
Julian A. Aiken
Emily G. Hoffman
Sara C. Atherley
Sabrina Champsi
Nadia Aleali
Dorsa Shakeri
Maya El-Zahed
Nicky Akbarian
4 more
Michael C. Riddell

Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes

doi 10.3389/fphar.2024.1302015

1,136 views
1 citation

MINI REVIEW

Published on 23 Jan 2024

Experimental pharmacological approaches to reverse impaired awareness of hypoglycemia—a review

Hiba Z. Hashmi
Ameer Khowaja
Amir Moheet

doi 10.3389/fphar.2024.1349004

1,074 views
1 citation

REVIEW

Published on 17 Jan 2024

Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes

Emily G. Hoffman
Ninoschka C. D’Souza
Richard T. Liggins
Michael C. Riddell

Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes

doi 10.3389/fphar.2023.1295639

2,026 views
3 citations

REVIEW

Published on 27 Nov 2023

The effect of insulin analogs in people with type 1 diabetes at increased risk of severe hypoglycemia

Sofie Broeng-Mikkelgaard
Julie Maria Bøggild Brøsen
Peter Lommer Kristensen
Birger Thorsteinsson
Ulrik Pedersen-Bjergaard

The effect of insulin analogs in people with type 1 diabetes at increased risk of severe hypoglycemia

doi 10.3389/fphar.2023.1301931

1,321 views

REVIEW

Published on 24 Oct 2023

Current and future therapies to treat impaired awareness of hypoglycemia

Erica L. Macon
Micah H. Devore
Yu Kuei Lin
Megan B. Music
Mason Wooten
Colleen A. McMullen
Andrea M. Woodcox
Ashlee R. Marksbury
Zachary Beckner
3 more
Simon J. Fisher

Current and future therapies to treat impaired awareness of hypoglycemia

doi 10.3389/fphar.2023.1271814

3,720 views
6 citations

ORIGINAL RESEARCH

Published on 06 Dec 2022

Screening of GPCR drugs for repurposing in breast cancer

Noor Mazin Abdulkareem
Raksha Bhat
Reid T. Powell
Soumya Chikermane
Soham Yande
Lisa Trinh
Hala Y. Abdelnasser
Mantasha Tabassum
Alexis Ruiz
8 more
Meghana V. Trivedi

Screening of GPCR drugs for repurposing in breast cancer

doi 10.3389/fphar.2022.1049640

3,918 views
7 citations

ORIGINAL RESEARCH

Published on 01 Dec 2022

Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex

Yongmei Feng
Stefan Grotegut
Predrag Jovanovic
Valentina Gandin
Steven H. Olson
Rabi Murad
Anne Beall
Sharon Colayco
Paul De-Jesus
5 more
Ze’ev A. Ronai

Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex

doi 10.3389/fphar.2022.1029093

3,543 views
1 citation

ORIGINAL RESEARCH

Published on 28 Nov 2022

Pharmacokinetics of fluorobenzyl polyethylene glycol conjugated tetraiodothyroacetic acid (NP751), a novel anticancer thyrointegrin αvβ3 antagonist

Kazutoshi Fujioka
Bruce A. Hay
Kavitha Godugu
Shaker A. Mousa

Pharmacokinetics of fluorobenzyl polyethylene glycol conjugated tetraiodothyroacetic acid (NP751), a novel anticancer thyrointegrin αvβ3 antagonist

doi 10.3389/fphar.2022.902141

990 views
3 citations

REVIEW

Published on 04 Oct 2022

Advances in stromal cell therapy for management of Alzheimer’s disease

Rashi Srivastava
Aidong Li
Tirtharaj Datta
Niraj Kumar Jha
Salehikram Talukder
Saurabh Kumar Jha
Zhe-Sheng Chen

Advances in stromal cell therapy for management of Alzheimer’s disease

doi 10.3389/fphar.2022.955401

1,556 views
4 citations

Share on

Frontiers in Pharmacology

Frontiers in Pharmacology

Experimental Pharmacology and Drug Discovery

Impact

38kTopic views
16kArticle views
5,669Article downloads